Inogen Inc. Files 8-K on Financials

Ticker: INGN · Form: 8-K · Filed: Nov 5, 2025 · CIK: 1294133

Inogen Inc 8-K Filing Summary
FieldDetail
CompanyInogen Inc (INGN)
Form Type8-K
Filed DateNov 5, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: INGN

TL;DR

Inogen Inc. filed an 8-K on Nov 5, 2025, detailing financial results and condition.

AI Summary

On November 5, 2025, Inogen Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial statements and exhibits. The report was filed with the SEC and is publicly available.

Why It Matters

This 8-K filing provides an update on Inogen Inc.'s financial performance and condition, which is crucial information for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

  • Inogen Inc. (company) — Registrant
  • November 05, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • 859 Ward Drive, Goleta, California 93111 (address) — Principal Executive Offices
  • (805) 562-0500 (phone_number) — Registrant's Telephone Number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Inogen Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on November 05, 2025.

In which state is Inogen Inc. incorporated?

Inogen Inc. is incorporated in Delaware.

What is Inogen Inc.'s principal executive office address?

Inogen Inc.'s principal executive office is located at 859 Ward Drive, Goleta, California 93111.

What is the telephone number for Inogen Inc.?

Inogen Inc.'s telephone number, including area code, is (805) 562-0500.

Filing Stats: 497 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-11-05 07:36:22

Key Financial Figures

  • $0.001 — nge on which registered Common Stock, $0.001 par value INGN The Nasdaq Stock Mar

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On November 5, 2025, Inogen, Inc. (the "Company") issued a press release reporting its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth under this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release dated November 5, 2025 . 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INOGEN, INC. Date: November 5, 2025 By: /s/ Michael Bourque Michael Bourque Executive Vice President Chief Financial Officer Treasurer (Principal Accounting and Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.